Researchers Find Chink in HIV-1's Armor

The Faculty of 1000 is aWeb-based literature awareness tool published by BioMed Central. For more information visit www.facultyof1000.com. Viruses are evolutionary wiseguys; they have devised elaborate weapons that allow them to sneak past immune system defenses. But a team at King's College, London, has shown that in the case of HIV-1 infection, some human T cells are not completely vulnerable to an HIV-1 viral attack. Michael Malim and colleagues have found a human gene, CEM15, whose product

Written byNicole Johnston
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Viruses are evolutionary wiseguys; they have devised elaborate weapons that allow them to sneak past immune system defenses. But a team at King's College, London, has shown that in the case of HIV-1 infection, some human T cells are not completely vulnerable to an HIV-1 viral attack. Michael Malim and colleagues have found a human gene, CEM15, whose product actually inhibits HIV-1 infection and may eventually provide a potential new target for drug therapy.1 Yet, the wiseguy mien has not completely disappeared: While the protein encoded by the newly discovered gene normally protects certain T cells against HIV-1 infection, its antithesis, Vif (viral infectivity factor), overcomes CEM15 and establishes the disease.

"This is the first intracellular gene product that I know of," says John Moore, professor of microbiology and immunology at Cornell University. "That there was such a factor to find has been suspected for two or three years. ... ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies